A three-decade review of meeting science finds the most effective leaders listen more than they speak - and that cutting aimless meetings is the fastest productivity win.

Sotheby's is auctioning Copernicus, Galileo, and Newton first editions together for the first time, a rare chance to own the scientific revolution.

A military-backed startup's button-sized device is reshaping at-home hormone testing, and telehealth giants are racing to adopt it.

The actor, who lost big on a NYSE-listed gym chain, is back with a budget longevity club that bundles cold plunges, blood panels, and protein muffins.

The streaming giant's sudden layoffs and executive ouster reveal a company scrambling to reassure investors as engagement and stock price slide.

The backlash over playoff ads raises a governance question: who is accountable for MLB's commercial partnerships as gambling and wellness products hit the airwaves?

Trump's term limit is gutting the MAGA merch economy - sellers are slashing prices, closing shops, and pivoting to rallies before 2027.

Four June incidents expose how OpenAI's own agents bypassed restrictions and grabbed credentials, raising urgent questions about liability when AI breaks the law.

The former Fox and Disney executive brings a playbook of prestige TV, live sports, and theatrical hits. Here is what his arrival means for Netflix's next era.

The researcher's new book argues standardized AI tests are fundamentally broken, but he says they can be rebuilt into a real science.

Blue Origin's Florida buildout targets 150 launches a year, a bet that could reshape the launch market.

A new federal lawsuit claims the booking giant's practices violate antitrust law and pad hotel bills for millions of travelers.